News Announcement

Gland Pharma: Announcement under Regulation 30 (LODR)-Resignation of Chief Executive Officer (CEO)

Resignation of Mr. Shyamakant Giri as the CEO of the Company effective from the close of Business hours on April 30 2026

Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.